Predictors of death within 6 months after non-ST elevation myocardial infarction in post-COVID-19 patients

Chashchin, M. G.; Gorshkov, A. Yu.; Drapkina, О. М.

doi:10.17116/profmed20222504147

Cited by 3 publications

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…But mortality is not the only adverse consequence of COVID-19. Many survivors of COVID-19 may develop PASC often calls long COVID [17], and presumed to be fatal [19].…”

Section: Introductionmentioning

confidence: 99%

Post-acute Sequelae of COVID-19 Case Fatality Rate and its Associated Covariates: A Systematic Review, Meta-Analysis and Meta-Regression

Muthuka

Nabaweesi

Nzioki

et al. 2023

AJFE

View full text Add to dashboard Cite

Background. Long COVID is a wide range of new, returning, or ongoing health problems experienced after primary COVID-19 infection, with a possibility of broad adverse outcomes. The aim of this study was to determine the case fatality of of post-acute sequelae of COVID-19 (PASC) and assess possible covariates. Population and Methods. We conducted a systematic review and meta-analysis from 43 studies (367,236 patients), (June, 2020 - August, 2022). PASC mortality was assessed from six studies. With random-effects model, the pooled case fatality was measured. Publication bias was ascertained and meta-regression analysis done on predetermined covariates. Results. The estimated prevalence of PASC was 42.5% (95% CI = 36.0 % - 49.3%). The pooled case fatality was 7.4% (95% CI = 7.4% to 11.2%). The funnel plot suggested the presence of publication bias. Hospital re-admission (P = 0.0034) (R² = 1.00) and the year 2021 (P = 0.0309) (R² = 0.55) were associated with fatalities from PASC. Discussion. PASC increased the case-fatality of COVID-19, particularly during the year 2021, reflecting a longer follow-up of patients and with hospital re-admission. It is recommended to monitor patients re-admitted to hospital post index COVID-19 closely monitor specific clinical parameters that may increase the risk of death.

show abstract

“…But mortality is not the only adverse consequence of COVID-19. Many survivors of COVID-19 may develop PASC often calls long COVID [17], and presumed to be fatal [19].…”

Section: Introductionmentioning

confidence: 99%

Post-acute Sequelae of COVID-19 Case Fatality Rate and its Associated Covariates: A Systematic Review, Meta-Analysis and Meta-Regression

Muthuka

Nabaweesi

Nzioki

et al. 2023

AJFE

View full text Add to dashboard Cite

show abstract

Dynamics and structure of mortality from chronic coronary artery disease among men and women in the Russian Federation in 2014-2023

Shepel,

Samorodskaya,

Kakorina

et al. 2024

Russ J Cardiol

View full text Add to dashboard Cite

Aim. To assess the dynamics of non-standardized (NSMR) and standardized mortality rates (SMR) of chronic coronary artery disease (CAD), the contribution to all-cause mortality, as well as the dynamics and structure of chronic CAD among men and women in the Russian Federation in 2014-2023.Material and methods. Rosstat data on mortality in one-year age groups of patients for 2014-2023 in accordance with the Rosstat Brief Nomenclature of Death Causes. The calculations were performed using the program (certificate of state registration of the computer program dated September 30, 2016, № 201666114). The European standard (European Standard Population, 1976) was used to calculate the SMR.Results. A decrease in the SMR from chronic CAD was found in both women (2014 — 147,6 per 100 thousand population, 2023 — 126 per 100 thousand population) and men (2014 — 275 per 100 thousand population, 2023 — 221 per 100 thousand population). The NCMR differences in men and women did not exceed 5%, while the SMR from chronic CAD differed by almost 2 times due to the age disproportion (in age ≥80 years in women, there were 60% of deaths from chronic CAD, while in men — 23,6%). The proportion of chronic CAD in all-cause mortality in men was 23,9%, while in women — 23,4%. The highest values of SMR were recorded from "I25.1 Atherosclerotic heart disease" (the proportion in the chronic CAD structure in 2014 in women — 64,5%, in men — 56,8%; in 2023 — 60,4% and 51,4%, respectively). In both men and women, the SMR and the proportion of "I25.2-6,8 Other forms of chronic CAD" in the structure of SMR from chronic CAD increased (in 2014 in women — 21,5%, in men — 29,3%, in 2023 — 37% and 46%, respectively). The SMR from I25.0 and I25.9 significantly decreased, amounting to <4% in the structure of chronic CAD in both men and women in 2023.Conclusion. The obtained results indicate problems with defining individual forms of chronic CAD as the underlying cause of death, which complicates understanding the death causes. It is necessary to consider creating uniform guidelines for the Russian Federation, where the classification of chronic CAD according to ICD-10 would be adapted to the clinical terminology and the most probable clinical variants, as well as the main principles of morphological classification. Typification of coding approaches will serve to improve the quality of analysis of chronic CAD mortality statistics data and subsequent adoption of targeted management decisions.

show abstract

Significance of biochemical markers of myocardial injury in patients with acute myocardial infarction and COVID-19

Petrova,

Tverdokhlebova,

Shashin

et al. 2024

jour

View full text Add to dashboard Cite

Clinical and instrumental data of patients with acute myocardial infarction are of little informative value for COVID-19 identification. The aim is to study the significance of myocardial injury markers on admission in patients with acute myocardial infarction on COVID-19 background. At admission to the hospital in 20 patients with acute myocardial infarction and COVID-19 in blood markers of myocardial damage (highly sensitive troponin T, myoglobin and creatine kinase MB fraction) were studied using immunochemiluminescent method on immunoenzyme analyzer “Cobas e 411” (“Roche Diagnostics”, Germany). The values of highly sensitive troponin T in patients with acute myocardial infarction and COVID-19 were significantly lower than in patients with acute myocardial infarction without COVID-19 (94.8 vs. 171.8 pg/ml). There were no statistically significant differences in the values of myoglobin and the MB creatine kinase fraction in the study groups. Thus, markers of myocardial damage in patients with acute myocardial infarction have no predictive value in relation to COVID-19.

show abstract

Predictors of death within 6 months after non-ST elevation myocardial infarction in post-COVID-19 patients

Cited by 3 publications

References 25 publications

Post-acute Sequelae of COVID-19 Case Fatality Rate and its Associated Covariates: A Systematic Review, Meta-Analysis and Meta-Regression

Post-acute Sequelae of COVID-19 Case Fatality Rate and its Associated Covariates: A Systematic Review, Meta-Analysis and Meta-Regression

Dynamics and structure of mortality from chronic coronary artery disease among men and women in the Russian Federation in 2014-2023

Significance of biochemical markers of myocardial injury in patients with acute myocardial infarction and COVID-19

Contact Info

Product

Resources

About